VECTORY
DEAD

Serial Number

79374383

Owner

VectorY B.V.

Attorney

Douglas T. Johnson

Filing Date

Jun 16, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VECTORY Trademark

Serial Number: 79374383

VECTORY is a trademark filed by VectorY B.V. on June 16, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

VectorY B.V. (8 trademarks)

Science Park 408

Entity Type: 26

Trademark Details

Filing Date

June 16, 2023

Registration Date

Not Registered

Goods & Services

Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics

Viral systems, gene therapy systems, nucleic acid delivery systems, namely, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in nucleic acid-based therapy, gene therapy and cell therapy

Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; research and product development in the field of pharmaceutics

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 4, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 19, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 16, 2024 OPNR
ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Oct 7, 2024 MAB1
ABANDONMENT - EXPRESS MAILED
Oct 7, 2024 ABN1
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 29, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 29, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 9, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2023 REPR